Back

Evaluation of the effects of immunization against PCSK9 on selected microRNAs involved in cholesterol homeostasis.

27 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Lipids 2 Lipids ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

5 More presentations in this session

Presentation thumbnail
Simulated intervention and optimal timing for attenuating dyslipidaemia-related atherosclerotic progression in the young: a temporal inverse allocation analysis of the ALSPAC cohort
Doctor A. Agbaje (Kuopio, FI)
Abstract Slides
Presentation thumbnail
Elevated levels of Lp(a) are associated with coronary lesion complexity in patients hospitalized for an acute myocardial infarction: data from the French RICO Survey
Doctor M. Kouame (Abidjan, CI)
Abstract Slides
Presentation thumbnail
Association of propionate with coronary artery disease in a large cross-sectional study
Professor N. Pagonas (Neuruppin, DE)
Abstract Slides
Presentation thumbnail
Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries.
Doctor E. Apostolou (London, GB)
Abstract Slides
Presentation thumbnail
Realistic approach to evaluate the effect of baseline lipid profile in post cardiac surgery: Restricted Cubic Spline model
Doctor A. Sheikhy (Tehran, IR)
Abstract Slides

Access the full session

Session thumbnail
Lipids 2

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources